Trial Watch: Peptide-based anticancer vaccines-Reference-Cited by-同舟云学术

Trial Watch: Peptide-based anticancer vaccines

Published:2015-01-09 Issue:4 Volume:4 Page:e974411
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Pol Jonathan,Bloy Norma,Buqué Aitziber,Eggermont Alexander,Cremer Isabelle,Sautès-Fridman Catherine,Galon Jérôme,Tartour Eric,Zitvogel Laurence,Kroemer Guido,Galluzzi Lorenzo

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/2162402X.2014.974411

Reference273 articles.

1. A new role for NFκB in immunosurveillance and its implications for cancer immunotherapy

2. Cancer immunoediting: from immunosurveillance to tumor escape

3. Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity

4. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective;Vaccines;2024-08-22

2. Advancing Peptide-Based Cancer Therapy with AI: In-Depth Analysis of State-of-the-Art AI Models;Journal of Chemical Information and Modeling;2024-06-14

3. Principles of risk assessment in colon cancer: immunity is key;OncoImmunology;2024-04-30

4. Digital Pathology for Better Clinical Practice;Cancers;2024-04-26

5. Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological Diseases;Biomedicines;2024-03-21